The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes
- PMID: 20529352
- PMCID: PMC2895612
- DOI: 10.1186/1471-2407-10-267
The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes
Abstract
Background: Lymph node status is the most important prognostic factor for colorectal cancer. The number of lymph nodes that should be histologically examined has been controversial. The aims of this study were to assess the impact of the number of lymph nodes examined on survival of patients with stage II colorectal cancer and to determine the optimal number of lymph nodes that should be examined.
Methods: The study included 664 patients who underwent resection for stage II colorectal cancer. The clinical and histopathologic data of the patients were prospectively collected and analyzed.
Results: The median number of lymph nodes examined was 12 (range: 1 to 58). The 5-year disease free survival rate was significantly higher for patients with 12 or more lymph nodes examined compared to those with less than 12 lymph nodes examined. The significant difference in 5-year disease free survival persisted if the dividing number increased progressively from 12 to 23. However, the difference in survival was most significant (lowest p value and highest hazard ratio) for the number 21. The 5-year disease free survival of patients with 21 or more lymph nodes examined was 80% whereas that of patients with less than 21 lymph nodes examined was 60% (p = 0.001, hazard ratio 2.08). Multivariate analysis showed that 21 or more lymph nodes examined was a factor that independently influenced survival. The 5-year disease free survival also increased progressively with the number of lymph node examined up to the number 21. After the number 21, the survival rate did not increase further. It was likely that 21 was the optimal number, at and above which the chance of lymph node metastasis was minimal.
Conclusions: The number of lymph nodes examined in colorectal cancer specimen significantly influences survival. It is recommended that at least 21 lymph nodes should be examined for accurate diagnosis of stage II colorectal cancer.
Figures
Similar articles
-
Prognostic value of the lymph node ratio in stage III colorectal cancer.Chin J Cancer. 2012 May;31(5):241-7. doi: 10.5732/cjc.011.10374. Epub 2012 Feb 7. Chin J Cancer. 2012. PMID: 22313594 Free PMC article.
-
Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.World J Surg. 2002 Mar;26(3):384-9. doi: 10.1007/s00268-001-0236-8. Epub 2002 Jan 15. World J Surg. 2002. PMID: 11865379
-
Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer.Hepatogastroenterology. 2004 Nov-Dec;51(60):1689-93. Hepatogastroenterology. 2004. PMID: 15532806
-
Lymph node staging in colorectal cancer: old controversies and recent advances.World J Gastroenterol. 2013 Dec 14;19(46):8515-26. doi: 10.3748/wjg.v19.i46.8515. World J Gastroenterol. 2013. PMID: 24379568 Free PMC article. Review.
-
Risk Stratification of T1 Colorectal Cancer Metastasis to Lymph Nodes: Current Status and Perspective.Gut Liver. 2021 Nov 15;15(6):818-826. doi: 10.5009/gnl20224. Gut Liver. 2021. PMID: 33361548 Free PMC article. Review.
Cited by
-
Surgery has a key role for quality assurance of colorectal cancer screening programs: impact of the third level multidisciplinary team on lymph nodal staging.Int J Colorectal Dis. 2016 Mar;31(3):587-92. doi: 10.1007/s00384-015-2472-7. Epub 2015 Dec 29. Int J Colorectal Dis. 2016. PMID: 26715436
-
Application of Carbon Nanoparticles in Tracing Lymph Nodes and Locating Tumors in Colorectal Cancer: A Concise Review.Int J Nanomedicine. 2020 Dec 2;15:9671-9681. doi: 10.2147/IJN.S281914. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33293812 Free PMC article. Review.
-
Adequate lymph node recovery improves survival in colorectal cancer patients.J Surg Oncol. 2013 Jun;107(8):828-34. doi: 10.1002/jso.23332. Epub 2013 Apr 16. J Surg Oncol. 2013. PMID: 23592545 Free PMC article.
-
Predictors and survival outcomes of having less than 12 harvested lymph nodes in proctectomy for rectal cancer.Int J Colorectal Dis. 2023 Sep 9;38(1):225. doi: 10.1007/s00384-023-04518-2. Int J Colorectal Dis. 2023. PMID: 37688758
-
Prognostic Value of Metastatic Lymph Node Ratio and Identification of Factors Influencing the Lymph Node Yield in Patients Undergoing Curative Colon Cancer Resection.Cancers (Basel). 2024 Jan 2;16(1):218. doi: 10.3390/cancers16010218. Cancers (Basel). 2024. PMID: 38201643 Free PMC article.
References
-
- Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, Jones J, Mamounas EP, Ore L, Petrelli NJ. The benefits of leucovorin - modulated fluorouracil as postoperative therapy for primary colon cancers: results from the National Surgical Adjuvant Breast and Bowel Project. J Clin Oncol. 1993;11:1879–87. - PubMed
-
- Fielding LP, Arsenault PA, Chapuis PH, Dent O, Gathright B, Hardcastle JD, Hermanek P, Jass JR, Newland RC. Clinicopathologic staging for colorectal cancer: an international documentation system (IDS) and an international comprehensive anatomical terminology (ICAT) J Gastroenterol Hepatol. 1991;6:325–44. doi: 10.1111/j.1440-1746.1991.tb00867.x. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical